Your browser doesn't support javascript.
loading
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain.
Ribera, Josep-Maria; García, Olga; Buendía-Ureña, Buenaventura; Terol, Maria-José; Vicent, Ana; Vall-Llovera, Ferran; Bergua, Juan; García-Cadenas, Irene; Esteve, Jordi; Ribera, Jordi; Acuña-Cruz, Evelyn; Herrera, Pilar; Hernández-Rivas, Jesus-Maria; Abrisqueta, Pau; González-Campos, José; Rodríguez, Carlos; Bastos-Oreiro, Mariana; Genescà, Eulàlia; Caminos, Nerea; Queipo de Llano, Maria-Paz; Cladera, Antònia; Sancho, Juan-Manuel.
Affiliation
  • Ribera JM; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • García O; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Buendía-Ureña B; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Terol MJ; Hematology Department, Hospital Clínico, Valencia, Spain.
  • Vicent A; Hematology Department, ICO-Hospital Joan XXIII, Tarragona, Spain.
  • Vall-Llovera F; Hematology Department, Hospital Mútua Terrassa, Terrassa, Spain.
  • Bergua J; Hematology Department, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • García-Cadenas I; Hematology Department, Hospital de Sant Pau, Barcelona, Spain.
  • Esteve J; Hematology Department, Hospital Clínic, Barcelona, Spain.
  • Ribera J; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Acuña-Cruz E; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Herrera P; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
  • Hernández-Rivas JM; Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Abrisqueta P; Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • González-Campos J; Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Rodríguez C; Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • Bastos-Oreiro M; Hematology Department, Hospital Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Genescà E; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Caminos N; Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
  • Queipo de Llano MP; Hematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Cladera A; Hematology Department, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain.
  • Sancho JM; Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Universitat Autònoma de Barcelona, Barcelona, Spain.
Leuk Lymphoma ; 63(8): 1993-1996, 2022 08.
Article in En | MEDLINE | ID: mdl-35343365
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: